Phage RDP-EC-20159 capable of splitting stable-phase escherichia coli as well as bactericidal composition and application of bacteriophage RDP-EC-20159
The invention provides an Escherichia coli bacteriophage RDP-EC-20159, the Escherichia coli bacteriophage is preserved in China General Microbiological Culture Collection Center (CGMCC) on October 28, 2022, and the preservation number of the Escherichia coli bacteriophage is CGMCC NO.45297. The Esch...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
07.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides an Escherichia coli bacteriophage RDP-EC-20159, the Escherichia coli bacteriophage is preserved in China General Microbiological Culture Collection Center (CGMCC) on October 28, 2022, and the preservation number of the Escherichia coli bacteriophage is CGMCC NO.45297. The Escherichia coli bacteriophage RDP-EC-20159 can be The invention also provides a bactericidal composition, and the bactericidal composition comprises the escherichia coli bacteriophage RDP-EC-20159 as described above. Preferably, the bactericidal composition also comprises a penicillin antibiotic drug. The invention also provides an application of the escherichia coli bacteriophage RDP-EC-20159 or the bactericidal composition in splitting pathogenic escherichia coli in a stable phase. The invention further provides an application of the escherichia coli bacteriophage RDP-EC-20159 or the bactericidal composition. The invention further provides application of the coliphage RDP-EC-20159 or the bactericidal composition in |
---|---|
Bibliography: | Application Number: CN202410258069 |